With regards to the gel not using the thermalife formulation I would suggest its because the company wants to reach out to the cheaper end of the market for muscle pain. by not using the peptide production costs would be much less.
For it to sell it would need to offer something new. There are already enough such products.
With regards to the gel not using the thermalife formulation I...
Add CAI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $98.92M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.5¢ | 13.0¢ | $311.2K | 2.336M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 301576 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 788662 | 7 |
View Market Depth
| Last trade - 16.10pm 29/04/2024 (20 minute delay) ? |
|
|||||
|
Last
13.5¢ |
Change
0.000 ( 3.85 %) |
||||
| Open | High | Low | Volume | ||
| 13.0¢ | 13.5¢ | 13.0¢ | 442979 | ||
| Last updated 15.59pm 29/04/2024 ? | |||||
| CAI (ASX) Chart |